These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9157541)

  • 21. Drug-resistant HIV: predicting the future.
    Laurence J
    AIDS Read; 2001 Oct; 11(10):485-6. PubMed ID: 11708079
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV/AIDS: money matters.
    Roberts L; Jasny B
    Science; 2008 Jul; 321(5888):511. PubMed ID: 18653875
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV/AIDS in China. A new treatment campaign, but with limited weapons.
    Cohen J
    Science; 2004 Jun; 304(5676):1433. PubMed ID: 15178778
    [No Abstract]   [Full Text] [Related]  

  • 25. [Resistance tests to improve therapy. More specific use of AIDS drugs].
    Paukstadt W
    MMW Fortschr Med; 1999 Sep; 141(37):18. PubMed ID: 10897968
    [No Abstract]   [Full Text] [Related]  

  • 26. Emerging HIV drug resistance in Africa.
    AIDS Read; 2000 Aug; 10(8):468. PubMed ID: 10967804
    [No Abstract]   [Full Text] [Related]  

  • 27. The HIV disbeliever.
    France D
    Newsweek; 2000 Aug; 136(9):46-9. PubMed ID: 11066588
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug targets cellular enzyme.
    AIDS Patient Care STDS; 1999 Apr; 13(4):247-8. PubMed ID: 10351898
    [No Abstract]   [Full Text] [Related]  

  • 29. Rapid assay for HIV drug resistance.
    Am Fam Physician; 1997 Oct; 56(6):1676-7. PubMed ID: 9351434
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antiretroviral therapy. A brief profile of all available drugs].
    Jablonowski H
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():18-29. PubMed ID: 10863306
    [No Abstract]   [Full Text] [Related]  

  • 31. Open freezer at NCI.
    Science; 1992 Jan; 255(5040):27. PubMed ID: 1553526
    [No Abstract]   [Full Text] [Related]  

  • 32. The NCI's AIDS antiviral drug screening program.
    Yang SS
    Leukemia; 1995 Oct; 9 Suppl 1():S9-11. PubMed ID: 7475324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The multiple benefits associated with HIV drug-resistance mutation M184V.
    Bean P
    Am Clin Lab; 2002 Mar; 21(2):16-8. PubMed ID: 11993249
    [No Abstract]   [Full Text] [Related]  

  • 34. More HIV resistance testing needed, according to survey.
    AORN J; 2000 Aug; 72(2):307. PubMed ID: 11203501
    [No Abstract]   [Full Text] [Related]  

  • 35. All about AIDS.
    Science; 1995 Nov; 270(5238):919. PubMed ID: 7481792
    [No Abstract]   [Full Text] [Related]  

  • 36. "Drug holidays" provide no benefits in HIV treatment.
    Public Health Rep; 2004; 119(1):97. PubMed ID: 15174493
    [No Abstract]   [Full Text] [Related]  

  • 37. Patents. NIH declines to march in on pricing AIDS drug.
    Malakoff D
    Science; 2004 Aug; 305(5686):926. PubMed ID: 15310867
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV-1 drug resistance among untreated patients in India: Current status.
    Pachamuthu B; Shanmugam S; Nagalingeswaran K; Solomon SS; Solomon S; Solomon S
    J Postgrad Med; 2006; 52(3):183-6. PubMed ID: 16855318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Science and the control of AIDS.
    Varmus H; Nathanson N
    Science; 1998 Jun; 280(5371):1815. PubMed ID: 9669926
    [No Abstract]   [Full Text] [Related]  

  • 40. A personal perspective on HIV-AIDS research.
    Gallo RC
    J Hum Virol; 1999; 2(1):8-18. PubMed ID: 10200595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.